MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has received a notice from the New York Stock Exchange (NYSE) regarding its non-compliance with continued listing standards under Section 802.01B of the NYSE Listed Company Manual. The notification stems from the company’s average global market capitalization falling below $50 million over a 30-day trading period, coupled with stockholders’ equity reported at less than $50 million as of December 31, 2024.
According to the notice, Annovis Bio’s 30-day average market capitalization was approximately $37.9 million, while its stockholders’ equity stood at $9.3 million. Despite the situation, the company emphasized that its business operations and financial reporting obligations to the Securities and Exchange Commission remain unaffected.
Annovis Bio has 45 days from March 26, 2025, to submit a detailed plan to the NYSE outlining definitive actions it is taking to regain compliance within an 18-month timeframe. The plan, once submitted, will undergo review by the NYSE, which will determine whether the company has demonstrated a reasonable path to conformity with listing requirements.
If the compliance plan is accepted, Annovis Bio’s stock will continue to trade on the NYSE under its current ticker symbol, “ANVS.” During this period, the stock will carry a “.BC” designation to indicate its non-compliance status. However, the indicator will be removed if the company successfully meets listing standards. Should the NYSE reject the plan or the company fail to adhere to the agreed timeline, the exchange could initiate suspension and delisting procedures.
While the notice presents a challenge, Annovis Bio reassured stakeholders that it is committed to addressing the matter. The company also noted that the notification does not conflict with its material agreements or debt obligations.
The NYSE will conduct quarterly reviews to ensure the company’s progress toward compliance. Annovis Bio’s ability to maintain its listing depends on successful execution of its plan within the 18-month cure period.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.